Hepatitis C Knowledge and Recent Diagnosis Affect Hepatitis C Treatment Willingness in Persons Living With HIV

被引:1
|
作者
Cachay, Edward R. [1 ]
Torriani, Francesca J. [1 ]
Hill, Lucas [2 ]
Rajagopal, Amutha [1 ]
Yin, Jeffrey [2 ]
Bamford, Laura [1 ]
Mathews, William C. [3 ]
机构
[1] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, Dept Med, San Diego, CA USA
[2] Univ Calif San Diego, Owen Clin Unit, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA USA
[3] Univ Calif San Diego, Dept Med, San Diego, CA USA
关键词
health literacy; HCV knowledge; HIV literacy; treatment willingness; and HIV; HEALTH LITERACY; BARRIERS; PROJECT; CARE;
D O I
10.1097/QAI.0000000000002643
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We assessed the impact of health literacy and hepatitis C (HCV) knowledge on HCV treatment willingness among people living with HIV (PLWH) at an academic HIV clinic. Methods: Cross-sectional analysis of PLWH coinfected with HCV who completed health literacy, HIV literacy, and HCV knowledge inventories. We estimated the prevalence of low health literacy, HIV knowledge, and HCV knowledge sampled from 3-comparison groups: PLWH not referred for HCV, referred but who "not showed" to the HCV clinic, and referred and attended the HCV clinic. We used mixed-model linear and logistic regression to ascertain predictors of low health literacy, HIV knowledge, HCV knowledge, and predictors of willingness to start HCV treatment. Results: We enrolled 151 PLWH; 17% were female, 38% non-White, and 60% without a high-school education. Approximately, 68% were men who have sex with men, of whom 62% used intravenous drugs. The prevalence of low health, HIV knowledge, and HCV knowledge was 10%, 32%, and 29%, respectively. Predictors of low health literacy were being Hispanic, cirrhotic, and not completing high-school education. Low HCV knowledge was observed in female, non-White, and those diagnosed with HCV for a decade. In adjusted analyses, PLWH living with HCV for a decade (OR: 0.23) were less likely to be very willing to be treated for HCV. By contrast, those with high HCV knowledge were more likely to be very willing to receive treatment (OR: 1.27). Conclusion: Low HCV knowledge and living with HCV for at least a decade are under-recognized negative predictors for PLWH's willingness to receive HCV treatment.
引用
收藏
页码:E159 / E166
页数:8
相关论文
共 50 条
  • [1] Options for treatment of hepatitis C in HIV-infected persons
    Thomas, DL
    JOURNAL OF HEPATOLOGY, 2006, 44 : S40 - S43
  • [2] Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
    MacBrayne, Christine E.
    Kiser, Jennifer J.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 : S12 - S23
  • [3] Predictors of hepatitis C treatment failure in people living with HIV
    Valle, Alan Sinuhe Medina
    Portillo, Elizabeth Mendoza
    Solorio, Humberto Gudino
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 328 - 329
  • [4] Improving access to hepatitis C treatment for people living with HIV
    Mellor, Justine
    Pears, Esther
    Prince, Martin
    Lee, Vincent
    HIV MEDICINE, 2022, 23 : 92 - 92
  • [5] An Epidemiologic Update on Hepatitis C Infection in Persons Living With or at Risk of HIV Infection
    Kim, Arthur Y.
    Onofrey, Shauna
    Church, Daniel R.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 : S1 - S6
  • [6] Treatment of hepatitis C in HIV-infected persons: A work in progress
    Sulkowski, Mark
    JOURNAL OF HEPATOLOGY, 2008, 48 (01) : 5 - 7
  • [7] Diagnosis and treatment of hepatitis C
    D'Souza, R
    Foster, GR
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2004, 97 (05) : 223 - 225
  • [8] Hepatitis C: Diagnosis and Treatment
    Wilkins, Thad
    Malcolm, Jennifer K.
    Raina, Dimple
    Schade, Robert R.
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (11) : 1351 - 1357
  • [9] Treatment algorithm for the management of hepatitis C in HIV-coinfected persons
    Sulkowski, MS
    JOURNAL OF HEPATOLOGY, 2006, 44 : S49 - S55
  • [10] Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons
    Thomas, David L.
    Bartlett, John G.
    Peters, Marion G.
    Sherman, Kenneth E.
    Sulkowski, Mark S.
    Pham, Paul A.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (07) : 979 - 983